Therapeutic plasma exchange for acute inflammatory demyelinating syndromes of the central nervous system

Journal of Clinical Apheresis

Volumn 14, Issue 3, 1999, Pages 144-148

  Weinshenker, Brian G ^a  

^a MAYO CLINIC   (United States)

Author keywords

Acute disseminated encephalomyelitis; Acute transverse myelitis; Apheresis; Marburg's variant of multiple sclerosis; Multiple sclerosis; Plasma exchange; Plasmapheresis

Indexed keywords

CORTICOSTEROID;

CONFERENCE PAPER; DEMYELINATING DISEASE; ENCEPHALOMYELITIS; HUMAN; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PLASMAPHERESIS; T LYMPHOCYTE;

ACUTE DISEASE; CENTRAL NERVOUS SYSTEM DISEASES; DEMYELINATING DISEASES; HUMANS; MULTIPLE SCLEROSIS; NEURITIS; PLASMA EXCHANGE; RANDOMIZED CONTROLLED TRIALS; SYNDROME;

EID: 0032734862     PISSN: 07332459     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1101(1999)14:3<144::AID-JCA7>3.0.CO;2-R     Document Type: Conference Paper

References (38)

1. Weinshenker B, Miller D. MS: One disease or many? In: Siva A, Kesselring J, Thompson A, editors. Frontiers in multiple sclerosis. London: Martin Dunitz, Ltd. 1998.
2. Weinshenker B, Lucchinetti C. Acute leukoencephalopathies: differential diagnosis and investigation. Neurologist 1998;4:148-166.
3. Weinshenker BG. The natural history of multiple sclerosis. Neurol Clin 1995;13:119-146.
4. Runmarker B, Andersson C, Oden A, et al. Multivariate analysis of prognostic factors in multiple sclerosis. J Neurol 1994;241: 597-604.
5. Giubilei F, Sarrantonio A, Tisie P, et al. Four-year follow-up of a case of acute multiple sclerosis of the Marburg type. Ital J Neurol Sci 1997;18:163-166.
6. Ford B, Tampieri D, Francis G. Long-term follow-up of acute partial transverse myelopathy. Neurology 1992;42:250-252.
7. Scott TF, Bhagavatula K, Snyder PJ, Chieffe C. Transverse myelitis. Comparison with spinal cord presentations of multiple sclerosis. Neurology 1998;50:429-433.
8. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999;53:1107-1114.
9. Lucchinetti CF, Rodriguez M. The controversy surrounding the pathogenesis of the multiple sclerosis lesion. Mayo Clin Proc 1997;72:665-678.
10. Trapp B, Peterson J, Ransohoff R, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278-285.
11. Rodriguez M, Lennon VA. Immunoglobulins promote remyelination in the central nervous system [see comments]. Ann Neurol 1990;27:12-17.
12. Lassmann H, Brück W, Lucchinetti C, Rodriguez M. Remyelination in multiple sclerosis. Multiple Sclerosis 1997;3:133-136.
13. Matthews PM, Francis G, Antel J, Arnold DL. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis [published erratum appears in Neurology 1991 Nov;41(11):1828]. Neurology 1991;41:1251-1256.
14. Arnold DL, Matthews PM, Francis GS, O'Connor J, Antel JP. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol 1992;31: 235-241.
15. Allegretta M, Nicklas JA, Sriram S, Albertini RJ. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science 1990;247:718-721.
16. Lucchinetti CF, Brack W, Rodriguez M, Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol 1996;6:259-274.
17. Rieckman P, Albrecht M, Kitze B, et al. Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann Neurol 1995;37:82-88.
18. Storch MK, Piddlesden S, Haltia M, livanainen M, Morgan P, Lassmann H. Multiple sclerosis: in situ evidence for antibody-and complement-mediated demyelination. Ann Neurol 1998;43:465-471.
19. Genain CP, Cannella B, Hauser SL, Raine CS. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nature Med 1999;5:170-175.
20. Stefoski D, Schauf CL, McLeod BC, Haywood CP, Davis FA. Plasmapheresis decreases neuroelectric blocking activity in multiple sclerosis. Neurology 1982;32:904-907.
21. Buchwald B, Toyka K, Zielasek J, Weishaupt A. Schweiger S, Dudel J. Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study. Ann Neurol 1998;44:913-922.
22. Dau P, Johnson K, Panitch H, Bornstein M. Plasmapheresis in multiple sclerosis: Preliminary findings. Neurology 1980;30: 1023-1028.
23. Noseworthy J. Treatment of multiple sclerosis with plasma exchange. In: Rudick R, editor. Treatment of Multiple Sclerosis. London: Springer-Verlag. 1992. p 251-266.
24. Vamvakas E, Pineda A, Weinshenker B. Meta-analysis of clinical studies of the efficacy of plasma exchange in the treatment of chronic progressive multiple sclerosis. J Clin Apheresis 1995;10: 163-170.
25. Valbonesi M, Garelli S, Mosconi L, Zerbi D, Forlani G. Plasma exchange in the management of patients with multiple sclerosis: preliminary observations. Vox Sang 1981;41:68-73.
26. Kanter DS, Horensky D, Sperling RA, Kaplan JD, Malachowski ME, Churchill WH Jr. Plasmapheresis in fulminant acute disseminated encephelomyelitis. Neurology 1995;45:824-827.
27. Stricker RB, Miller R, Kiprov DD. Role of plasmapheresis in acute disseminated (postinfectious) encephelomyelitis. J Clin Apheresis 1992;7:173-179.
28. Seales D, Greer M. Acute hemorrhagic leukoencephalitis. A successful recovery. Arch Neurol 1991;48:1086-1088.
29. Newton R. Plasma exchange in acute post-infectious demyelination. Dev Med Child Neurol 1981;23:538-543.
30. Cotter F, Bainbridge D, Newland A. Neurological deficit associated with Mycoplasma pneumoniae reversed by plasma exchange. Br Med J 1983;286:22.
31. Khatri BO, D'Cruz O, Priesler G, Hambrook G, Worthington D. Plasmapheresis in a pregnant patient with multiple sclerosis [letter]. Arch Neurol 1990;47:11-12.
32. Aguilera AJ, Carlow TJ, Smith KJ, Simon TL. Lymphocytoplasmapheresis in Devic's syndrome. Transfusion 1985;25:54-56.
33. Dodick DW, Silber MH, Noseworthy JH, Wilbright WA, Rodriguez M, Acute disseminated encephalomyelitis after accidental injection of a hog vaccine: successful treatment with plasmapheresis. Mayo Clinic Proc 1998;73:1193-1195.
34. Flechtner KM, Baum K. Mixed connective tissue disease: recurrent episodes of optic neuropathy and transverse myelopathy. Successful treatments with plasmapheresis. J Neurol Sci 1994;126: 146-148.
35. Konttinen YT, Kinnunen E, von Bonsdorff M, et al. Acute transverse myelopathy successfully treated with plasmapheresis and prednisone in a patient with primary Sjogren's syndrome. Arthritis Rheum 1987;30:339-344.
36. Rodriguez M, Karnes WE, Bartleson JD, Pineda AA. Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination. Neurology 1993;43:1100-1104.
37. Palm M, Behm E, Schmitt E, et al. Immunoadsorption and plasma exchange in multiple sclerosis: complement and plasma protein behaviour. Biomat Art Cells & Immob Biotech 1991;19:283-296.
38. Weiner HL, Dau PC, Khatri BO, et al. Double-blind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis. Neurology 1989; 39:1143-1149.